The effect of Silymarin on VEGF, VEGFR-1 and IL-1α levels in placental cultures of severe preeclamptic women.
OBJECTIVE
The purpose of this study was to evaluate the effects of Silymarin on vascular endothelial growth factor (VEGF), soluble VEGF Receptor-1 (sVEGFR-1) and Interleukin-1 alpha (IL-1α) levels in placental tissue samples of severely preeclamptic women.


METHODS
We conducted an in vitro study in Başkent University Faculty of Medicine, Ankara, Turkey between September 2008 and May 2009. A total of 16 placental tissue samples (8 from severe preeclamptic, and 8 from controls) were analysed. Placental samples were incubated, and VEGF, sVEGFR-1, and IL1-α were measured in culture media using an ELISA kit. The effect of Silymarin on these levels was investigated. Descriptive statistics were initially performed, followed by Mann Whitney U-test and Kruskal-Wallis test to compare means between groups. P values less than 0.05 were considered statistically significant.


RESULTS
Eight patients were included in the severe preeclampsia (SP) group, whereas the remaining 8 patients were included in the control group. There were no significant correlations between gestational age and placental VEGF, sVEGFR-1 and IL-1α after 48 or 72 hours of incubation. Basal VEGF levels were lower in the SP group; however, it did not reach statistical significance. sVEGFR-1 and IL-1α levels were also similar between the SP and control groups (p>0.05). After 48 and 72 hours of incubation, sVEGFR-1 levels in Silymarin-added SP and control placental cultures were lower than in the samples without Silymarin addition; however, this difference also did not reach significance.


CONCLUSIONS
Although we could not demonstrate a significant effect on placental cytokines, considering the role of vasospasm, inflammation, angiogenesis, endothelial cell activation, and oxidative stress in preeclampsia, the potential benefits of Silymarin should be evaluated in future trials with a larger sample size.
Department of Obstetrics and Gynecology, Başkent University Faculty of Medicine, Ankara, Turkey.
Mustafa Derda
MD
Kaya
Department of Obstetrics and Gynecology, Başkent University Faculty of Medicine, Ankara, Turkey.
Eralp
E
Başer
Department of Obstetrics and Gynecology, Başkent University Faculty of Medicine, Ankara, Turkey.
Sibel
S
Kaya
Department of Obstetrics and Gynecology, Başkent University Faculty of Medicine, Ankara, Turkey.
Mustafa Kemal
MK
Takal
Department of Medical Genetics, Başkent University Faculty of Medicine, Ankara, Turkey.
Feride
F
Sahin
Department of Obstetrics and Gynecology, Başkent University Faculty of Medicine, Ankara, Turkey.
Esra
E
Kuşçu
Department of Obstetrics and Gynecology, Başkent University Faculty of Medicine, Ankara, Turkey.
Filiz
F
Yanık
Severe preeclampsia; Silymarin; placenta; vascular endothelial growth factor